7 results
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
inhibitors • Injection drug ... • HIV: 2/3 pulmonary ... Treatment: Active ... Initiating Treatment ... #Management #Treatment
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
inhibitors • Injection drug ... • HIV: 2/3 pulmonary ... Treatment: Active ... Initiating Treatment ... #Management #Treatment
RIPE Therapy - Drug Regimens for Microbiologically Confirmed Pulmonary Tuberculosis - IDSA Guidelines

#Tuberculosis #ActiveTB #RIPE #Therapy
RIPE Therapy - Drug ... Microbiologically Confirmed Pulmonary ... Tuberculosis - ... Therapy #regimens #medications ... IDSA #Guidelines #Treatment
IDSA Recommendations for Treating Mycobacterium Tuberculosis Infection and Disease in HIV-AIDS
Treating LTBI (to prevent TB disease)
Indications:
Mycobacterium Tuberculosis ... disease) Indications ... prior history of treatment ... tests, empiric treatment ... Mycobacterium #Tuberculosis
Erythemas Summarized
Erythema ab igne
 • A dermatosis that results from repeated exposure to heat (fires, heating
autoimmune conditions, medications ... associated with tuberculosis ... endemic mycoses, TB ... malignancies, and drugs ... PrathitKulkarni #Erythemas #comparison
Causes of Lactate Elevation, Lactic Acidosis - Differential Diagnosis

The most common causes of hyperlactatemia are usually:
circulation If drugs ... before beginning treatment ... output - Acute pulmonary ... - HIV/HAART medications ... #typea #typeb #classification
Causes of Unintentional Weight Loss - Differential Diagnosis
Malignancy 
 - Tumor effect* (esp. Gl, lung, lymphoma)
lymphoma) - Treatment ... Infections: HIV/AIDS, Tuberculosis ... cachexia"), COPD ("pulmonary ... cachexia") Medications ... GLP-I agonists Drugs